Pharmacological validation of a new animal model of alcoholism

Journal of Neural Transmission

Volumn 107, Issue 6, 2000, Pages 669-680

  Spanagel, R ^a   Holter S M ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Acamprosate; Alcoholism; Craving; Naltrexone; Relapse

Indexed keywords

ACAMPROSATE; ALCOHOL; NALTREXONE;

ABSTINENCE; ALCOHOL CONSUMPTION; ALCOHOL TOLERANCE; ALCOHOLISM; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CONTROLLED STUDY; NEUROBIOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; RELAPSE; STRESS; VALIDATION PROCESS; WITHDRAWAL SYNDROME;

EID: 0034114914     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007020070068     Document Type: Article

References (43)

1. al Qatari M, Bouchenafa O, Littleton J (1998) Mechanism of action of acamprosate, part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex. Alcohol Clin Exp Res 22: 810-814
2. Altshuler HL, Phillips PE, Feinhandler DA (1980) Alteration of ethanol self-administration by naltrexone. Life Sci 26: 679-688
3. Boismare F, Daoust M, Moore N, Saligaut C, Lhuintre J-P, Chretien P, Durlach J (1984) A homotaurine derivate reduced the voluntary intake of ethanol by rats: are cerebral GABA receptors involved? Pharmacol Biochem Behav 21: 787-789
4. Chabenat C, Chretien P, Daoust M, Moore N, Andre D, Lhuintre JP, Saligaut C, Boucly P, Boismare F (1988) Physiochemical, pharmacological and pharmacokinetic study of a new GABAergic compound, calcium acetylhomotaurinate. Meth Find Exp Clin Pharmacol 10: 311-317
5. Chiamulera C, Valerio E, Tessari M (1995) Resumption of ethanol-seeking behaviour in rats. Behav Pharmacol 6: 32-39
6. Cole JC, Littleton JM, Little HJ (2000) Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus maze. Psychopharmacology 147: 403-411
7. Dahchour A, De Witte P, Bolo N, Nedelec JF, Muzet M, Durbin P, Macher JP (1998) Central effects of acamprosate, part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res Neuroimaging 82: 107-114
8. Durlach J, Rinjard P, Sprince H, Smith GG (1988) Similar antagonistic effects of Ca N-acetylhomotaurinate on depression of motor activity and lethality induced by acetaldehyde or ethanol. Meth Find Exp Clin Pharmacol 10: 437-447
9. Gewiss M, Heidbreder C, Opsomer L, Durbin Ph, DeWitte Ph (1991) Acamprosate and diazepam differentially modulate alcohol-induced behavioural and cortical alterations in rats following chronic inhalation of ethanol vapour. Alcohol Alcoholism 26: 129-137
10. Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129: 99-111
11. Heyser JC, Schulteis G, Koob GF (1997) Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcohol Clin Exp Res 21: 784-791
12. Heyser CJ, Schulteis G, Durbin P, Koob GF (1998) Chronic acamprosate treatment eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Neuropsychopharmacology 18: 125-133
13. Hölter SM, Spanagel R (1999) Effects of opiate antagonist treatment on the alcohol deprivation effect in long-term ethanol-experienced rats. Psychopharmacology 145: 360-369
14. Hölter SM, Landgraf R, Zieglgänsberger W, Spanagel R (1997) Time course of acamprosate action on operant self-administration following ethanol deprivation. Alcohol Clin Exp Res 21: 862-869
15. Hölter SM, Engelmann M, Kirschke C, Liebsch G, Landgraf R, Spanagel R (1998a) Long-term ethanol self-administration with repeated withdrawal episodes changes ethanol drinking pattern and increases anxiety during withdrawal in rats. Behav Pharmacol 9: 41-48
16. Hölter SM, Linthorst ACE, Reul JMHM, Spanagel R (1998b) Withdrawal symptoms in a long-term model of alcohol self-administration in unselected Wistar rats. Alcohol Clin Exp Res [Suppl] 22(3): 92A
17. Hyytiä P (1993) Involvement of μ-opioid receptors in alcohol drinking by alcohol-preferring AA rats. Pharmacol Biochem Behav 45: 697-701
18. Iso H, Brush FR (1991) Opposite effects of naltrexone on ETOH intake by Syracuse high and low avoidance rats. Alcohol 8: 443-448
19. 2 opioid receptor antagonist naltriben selectively attenuates alcohol intake in rats bred for alcohol preference. Pharmacol Biochem Behav 52: 153-159
20. Krishnan-Sarin S, Wand GS, Li X-W, Portoghese PS, Froehlich JC (1998) Effect of mu opioid receptor blockade on alcohol intake in rats bred for high alcohol drinking. Pharmacol Biochem Behav 59: 627-635
21. Lê AD, Quan B, Juzytch W, Fletcher PJ, Joharchi N, Shaham Y (1998) Reinstatement of alcohol-seeking by priming injections of alcohol and exposure to stress in rats. Psychopharmacology 135: 169-174
22. Le Magnen J, Tran G, Durlach J, Martin C (1987a) Dose-dependent suppression of the high alcohol intake of chronically intoxicated rats by Ca-Acetyl homotaurinate. Alcohol 4: 97-102
23. Le Magnen J, Tran G, Durlach J (1987b) Lack of effects of Ca-acetyl homotaurinate on chronic and acute toxicities of ethanol in rats. Alcohol 4: 103-108
24. Littleton J (1995) Acamprosate in alcohol dependence: how does it work? Addiction 90: 1179-1188
25. Markou A, Weiss F, Gold LH, Caine B, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112: 163-182
26. Millan MJ, Morris BJ, Herz A (1988) Antagonist-induced opioid receptor up-regulation. I. Characterization of supersensitivity to selective μ and κ agonists. J Pharmacol Exp Ther 247: 721-728
27. Morris BJ, Millan MJ, Herz A (1988) Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of μ, δ and κ binding sites in rat brain revealed by quantitative autoradiography. J Pharmacol Exp Ther 247: 729-736
28. Naassila M, Hammoumi S, Legrand E, Durbin P, Daoust M (1998) Mechanism of action of acamprosate, part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain. Alcohol Clin Exp Res 22: 802-809
29. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B (1992) Naltrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry 49: 881-887
30. Phillips TJ, Wenger CD, Dorow JD (1997) Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL/6J mice. Alcohol Clin Exp Res 21: 691-702
31. Putzke J, Mahal B, Schadrack J, Spanagel R, Zieglgänsberger W (1997) NMDA receptor antagonists influence the expression of NMDA receptor subunits in the rat CNS. Pharmacopsychiatry 30: 208
32. Rassnick S, D'Amico E, Riley E, Pulvirenti L, Zieglgänsberger W, Koob GF (1992) GABA and nucleus accumbens glutamate neurotransmission modulate ethanol selfadministration in rats. Ann NY Acad Sci 654: 502-505
33. Richter CP, Campbell K (1940) Alcohol taste thresholds and concentration of solution preferred by rats. Science 91: 507-508
34. Schneider U, Wohlfahrt K, Schulze-Bonhage A, Haaker T, Caspary A, Zedler M. Emrich HM (1998) Lack of psychotomimetic or impairing effects on psychomotor performance of acamprosate. Pharmacopsychiatry 31: 110-113
35. Soyka M, Aichmüller C, Preuss U, Möller HJ (1998) Effects of acamprosate on psychomotor performance and driving ability in abstinent alcoholics. Pharmacopsychiatry 31: 232-235
36. Spanagel R, Zieglgänsberger W (1997) Anti-craving compounds: new pharmacological tools to study addictive processes. Trends Pharmacol Sci 18: 54-59
37. Spanagel R, Hölter SM (1999) Long-term alcohol self-administration with repeated alcohol deprivation phases: an animal model of alcoholism? Alcohol Alcoholism 34: 231-243
38. Spanagel R, Hölter SM (2000) Controversial research areas: a critical review. In: Zernig G, Saria A, Kurz A (eds) Handbook of alcoholism: clinical and theoretical approaches. CRC Press, Boca Raton, pp 401-413
39. Spanagel R, Hölter SM, Allingham K, Landgraf R, Zieglgänsberger W (1996a) Acamprosate and alcohol. I. Effects on alcohol intake following alcohol deprivation in the rat. Eur J Pharmacol 305: 39-44
40. Spanagel R, Putzke J, Zieglgänsberger W, Stefferl A, Schöbitz B (1996b) Acamprosate and alcohol. II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305: 45-50
41. Spanagel R, Zieglgänsberger W, Hundt W (1996c) Acamprosate and alcohol. III. Effects on alcohol discrimination in the rat. Eur J Pharmacol 305: 51-56
42. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP (1992) Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49: 876-880
43. Zeise ML, Kasparov S, Capogna M, Zieglgänsberger W (1993) Acamprosate (calciumacetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible involvement of excitatory amino acid receptors. Eur J Pharmacol 231: 47-52